Li, Yixing
Rosenblit, Paul D.
Article History
First Online: 26 September 2018
Compliance with Ethical Standards
:
: Yixing Li declares that he has no conflicts of interest.Paul D. Rosenblit reports the following: Clinical Research Trial site for Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers-Squib, Glaxo SmithKline, Ionis, Lexicon, Novo Nordisk, and Sanofi; Speaking/Teaching Honoraria from Akcea, Amgen, Janssen, Novo Nordisk, and Merck; and Advisory Board Honoraria from Akcea, Amarin, Amgen, Novo Nordisk, and Sanofi-Regeneron.
: This article does not contain any studies with human or animal subjects performed by any of the authors.